Your browser doesn't support javascript.
loading
The role of accessibility policies and other determinants of health care provision in the initial prognosis of malignant melanoma: a cross-sectional study.
Moreno-Ramírez, David; Ojeda-Vila, Teresa; Ríos-Martín, Juan J; Ruiz-Villaverde, Ricardo; de-Troya, Magdalena; Sanz-Trelles, Andres; Liébana, Rafael Fúnez; Martínez-de-Victoria, José M; Aneiros-Fernández, Jose; Naranjo-Sintes, Ramón; Amérigo, Joaquín; Alcalde, Mercedes; Zulueta, Teresa; Domínguez-Cruz, Javier J; Solís-García, Eduardo; Tejera-Vaquerizo, Antonio; Martín-Castro, Aurelio M; García-Mellado, Valentín; Martínez-García, Silvestre; Martínez-García, Araceli; Herrera-Acosta, Enrique; Escámez, Pilar Jurado; Rodríguez-Fernández, Antonio M; Salvatierra-Cuenca, Juan; Moreno-Giménez, José C; Guerrero-Cauqui, Rosario; Armario-Hita, Jose C; Nieto-Garcia, Adoración; Ferrándiz, Lara.
  • Moreno-Ramírez D; Hospital Universitario Virgen Macarena, Seville, Spain. Electronic address: david.moreno.ramirez.sspa@juntadeandalucia.es.
  • Ojeda-Vila T; Hospital Universitario Virgen Macarena, Seville, Spain.
  • Ríos-Martín JJ; Hospital Universitario Virgen Macarena, Seville, Spain.
  • Ruiz-Villaverde R; Complejo Hospitalario de Jaén, Jaén, Spain.
  • de-Troya M; Hospital Costa del Sol, Marbella-Málaga, Spain.
  • Sanz-Trelles A; Hospital Regional de Málaga, Málaga, Spain.
  • Liébana RF; Hospital Costa del Sol, Marbella-Málaga, Spain.
  • Martínez-de-Victoria JM; Complejo Hospitalario de Jaén, Jaén, Spain.
  • Aneiros-Fernández J; Hospital San Cecilio, Granada, Spain.
  • Naranjo-Sintes R; Hospital San Cecilio, Granada, Spain.
  • Amérigo J; Hospital Torrecárdenas, Almeria, Spain.
  • Alcalde M; Hospital Torrecárdenas, Almeria, Spain.
  • Zulueta T; Hospital Universitario Virgen del Rocío, Seville, Spain.
  • Domínguez-Cruz JJ; Hospital Universitario Virgen del Rocío, Seville, Spain.
  • Solís-García E; Hospital Infanta Margarita, Cabra-Córdoba, Spain.
  • Tejera-Vaquerizo A; Hospital Infanta Margarita, Cabra-Córdoba, Spain.
  • Martín-Castro AM; Hospital Universitario Virgen de las Nieves, Granada, Spain.
  • García-Mellado V; Hospital Universitario Virgen de las Nieves, Granada, Spain.
  • Martínez-García S; Hospital Regional de Málaga, Málaga, Spain.
  • Martínez-García A; Hospital Universitario Virgen de la Victoria, Málaga, Spain.
  • Herrera-Acosta E; Hospital Universitario Virgen de la Victoria, Málaga, Spain.
  • Escámez PJ; Hospital Infanta Elena, Huelva, Spain.
  • Rodríguez-Fernández AM; Hospital de Jerez de la Frontera, Cádiz, Spain.
  • Salvatierra-Cuenca J; Hospital Universitario Reina Sofía, Córdoba, Spain.
  • Moreno-Giménez JC; Hospital Universitario Reina Sofía, Córdoba, Spain.
  • Guerrero-Cauqui R; Hospital Punta de Europa, Algeciras-Cádiz, Spain.
  • Armario-Hita JC; Hospital Punta de Europa, Algeciras-Cádiz, Spain.
  • Nieto-Garcia A; Department of Preventive Medicine and Public Health, University of Seville, Spain.
  • Ferrándiz L; Hospital Universitario Virgen Macarena, Seville, Spain.
J Am Acad Dermatol ; 71(3): 507-15, 2014 Sep.
Article en En | MEDLINE | ID: mdl-24894454
ABSTRACT

BACKGROUND:

The prognostic benefit of health care service provision and delivery policies for patients with malignant melanoma (MM) is not yet clear.

OBJECTIVE:

To analyze the role of health care provision determinants in the initial prognosis of MM.

METHODS:

A multicenter cross-sectional study was conducted at 14 public hospitals and recruited 3550 patients with MM between 2000 and 2009. The study variables were analyzed using univariate and multivariate models to identify their role in the variations observed.

RESULTS:

In a 10-year period, the number of patients with MM increased by 78.54%, with primary in situ MM (Tis) or MMs with a Breslow thickness <1 mm (T1) representing 51.72% of the total number of MMs in 2000, increasing to 62.23% by the end of the study period (P = .005). Among the variables that explained the variation in MM frequency the year of diagnosis after 2004 (univariate odds ratio [OR], 1.43 [P < .001]; multivariate OR, 1.36 [P = .005]) and diagnosis in centers with specific fast-track referral systems (univariate OR, 1.24 [P = .01]; multivariate OR, 1.59 [P = .025]) were shown to explain the increasing frequency of Tis-T1 MM.

LIMITATIONS:

The primary potential limitation of this study is its retrospective nature.

CONCLUSION:

Health care provision policies and interventions aimed at improving accessibility to specialized care appear to explain the increasing frequency of Tis-T1 MM.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Accesibilidad a los Servicios de Salud / Melanoma Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male País como asunto: Europa Idioma: En Año: 2014 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Accesibilidad a los Servicios de Salud / Melanoma Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male País como asunto: Europa Idioma: En Año: 2014 Tipo del documento: Article